BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 15027080)

  • 1. Construction and validation of a prognostic model across several studies, with an application in superficial bladder cancer.
    Royston P; Parmar MK; Sylvester R
    Stat Med; 2004 Mar; 23(6):907-26. PubMed ID: 15027080
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Flexible parametric proportional-hazards and proportional-odds models for censored survival data, with application to prognostic modelling and estimation of treatment effects.
    Royston P; Parmar MK
    Stat Med; 2002 Aug; 21(15):2175-97. PubMed ID: 12210632
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dynamic Cox modelling based on fractional polynomials: time-variations in gastric cancer prognosis.
    Berger U; Schäfer J; Ulm K
    Stat Med; 2003 Apr; 22(7):1163-80. PubMed ID: 12652560
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic variables and prognostic groups for malignant melanoma. The information from Cox and Classification And Regression Trees analysis: an Italian population-based study.
    Crocetti E; Mangone L; Lo Scocco G; Carli P
    Melanoma Res; 2006 Oct; 16(5):429-33. PubMed ID: 17013092
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A machine learning-based approach to prognostic analysis of thoracic transplantations.
    Delen D; Oztekin A; Kong ZJ
    Artif Intell Med; 2010 May; 49(1):33-42. PubMed ID: 20153956
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Munich score: a clinical index to predict survival in ambulatory patients with chronic heart failure in the era of new medical therapies.
    Stempfle HU; Alt A; Stief J; Siebert U
    J Heart Lung Transplant; 2008 Feb; 27(2):222-8. PubMed ID: 18267231
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Time-to-event analysis with artificial neural networks: an integrated analytical and rule-based study for breast cancer.
    Lisboa PJ; Etchells TA; Jarman IH; Hane Aung MS; Chabaud S; Bachelot T; Perol D; Gargi T; Bourdès V; Bonnevay S; Négrier S
    Neural Netw; 2008; 21(2-3):414-26. PubMed ID: 18304780
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Initial high-grade T1 urothelial cell carcinoma: feasibility and prognostic significance of lamina propria invasion microstaging (T1a/b/c) in BCG-treated and BCG-non-treated patients.
    Orsola A; Trias I; Raventós CX; Español I; Cecchini L; Búcar S; Salinas D; Orsola I
    Eur Urol; 2005 Aug; 48(2):231-8; discussion 238. PubMed ID: 15963635
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of predictive accuracy of four prognostic models for nonmetastatic renal cell carcinoma after nephrectomy: a multicenter European study.
    Cindolo L; Patard JJ; Chiodini P; Schips L; Ficarra V; Tostain J; de La Taille A; Altieri V; Lobel B; Zigeuner RE; Artibani W; Guillé F; Abbou CC; Salzano L; Gallo C
    Cancer; 2005 Oct; 104(7):1362-71. PubMed ID: 16116599
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Empirical study of the dependence of the results of multivariable flexible survival analyses on model selection strategy.
    Binquet C; Abrahamowicz M; Mahboubi A; Jooste V; Faivre J; Bonithon-Kopp C; Quantin C
    Stat Med; 2008 Dec; 27(30):6470-88. PubMed ID: 18837067
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Validation by calibration of the UCLA integrated staging system prognostic model for nonmetastatic renal cell carcinoma after nephrectomy.
    Cindolo L; Chiodini P; Gallo C; Ficarra V; Schips L; Tostain J; de La Taille A; Artibani W; Patard JJ
    Cancer; 2008 Jul; 113(1):65-71. PubMed ID: 18473356
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Feasibility study of application of international prognostic score on prediction of prognosis for advanced Hodgkin's lymphoma].
    Fu XH; Wang SS; Huang Y; Wang B; Huang HQ; Zhang L; Sun XF; Xu RH; Lin TY
    Ai Zheng; 2006 Aug; 25(8):1013-8. PubMed ID: 16965685
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lymphovascular invasion is independently associated with poor prognosis in patients with localized upper urinary tract urothelial carcinoma treated surgically.
    Saito K; Kawakami S; Fujii Y; Sakura M; Masuda H; Kihara K
    J Urol; 2007 Dec; 178(6):2291-6; discussion 2296. PubMed ID: 17936818
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pretreatment levels of peripheral neutrophils and leukocytes as independent predictors of overall survival in patients with American Joint Committee on Cancer Stage IV Melanoma: results of the EORTC 18951 Biochemotherapy Trial.
    Schmidt H; Suciu S; Punt CJ; Gore M; Kruit W; Patel P; Lienard D; von der Maase H; Eggermont AM; Keilholz U; ;
    J Clin Oncol; 2007 Apr; 25(12):1562-9. PubMed ID: 17443000
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic model of event-free survival for patients with androgen-independent prostate carcinoma.
    Shulman MJ; Benaim EA
    Cancer; 2005 Jun; 103(11):2280-6. PubMed ID: 15844202
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prediction model for estimating the survival benefit of adjuvant radiotherapy for gallbladder cancer.
    Wang SJ; Fuller CD; Kim JS; Sittig DF; Thomas CR; Ravdin PM
    J Clin Oncol; 2008 May; 26(13):2112-7. PubMed ID: 18378567
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Histologic tumor growth pattern is significantly associated with disease-related survival in muscle-invasive transitional cell carcinoma of the urinary bladder.
    Krüger S; Noack F; Böhle A; Feller AC
    Oncol Rep; 2004 Sep; 12(3):609-13. PubMed ID: 15289845
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A prognostic index (bladder prognostic index) for bilharzial-related invasive bladder cancer.
    Khaled H; El Hattab O; Moneim DA; Kassem HA; Morsi A; Sherif G; Darwish T; Gaafar R
    Urol Oncol; 2005; 23(4):254-60. PubMed ID: 16018940
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Validation of patient's self-reported social functioning as an independent prognostic factor for survival in metastatic colorectal cancer patients: results of an international study by the Chronotherapy Group of the European Organisation for Research and Treatment of Cancer.
    Efficace F; Innominato PF; Bjarnason G; Coens C; Humblet Y; Tumolo S; Genet D; Tampellini M; Bottomley A; Garufi C; Focan C; Giacchetti S; Lévi F;
    J Clin Oncol; 2008 Apr; 26(12):2020-6. PubMed ID: 18421055
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prediction of survival for patients with bullous pemphigoid: a prospective study.
    Joly P; Benichou J; Lok C; Hellot MF; Saiag P; Tancrede-Bohin E; Sassolas B; Labeille B; Doutre MS; Gorin I; Pauwels C; Chosidow O; Caux F; Estève E; Dutronc Y; Sigal M; Prost C; Maillard H; Guillaume JC; Roujeau JC
    Arch Dermatol; 2005 Jun; 141(6):691-8. PubMed ID: 15967914
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.